Halozyme expands collaboration and license deal with argenx for ENHANCE development and commercialization with two additional targets

Halozyme Therapeutics has expanded its collaboration and license agreement with argenx covering the development and commercialization of ENHANCE, adding two additional targets to the deal.

Detected & updated continuously · Source: Nebula